India · Delayed Price · Currency is INR Oxygenta Pharmaceutical Statistics
Total Valuation
BOM:524636 has a market cap or net worth of INR 2.15 billion. The enterprise value is 2.86 billion.
| Market Cap | 2.15B |
| Enterprise Value | 2.86B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:524636 has 36.98 million shares outstanding. The number of shares has increased by 4.33% in one year.
| Current Share Class | 36.98M |
| Shares Outstanding | 36.98M |
| Shares Change (YoY) | +4.33% |
| Shares Change (QoQ) | -1.03% |
| Owned by Insiders (%) | 33.41% |
| Owned by Institutions (%) | n/a |
| Float | 3.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| PB Ratio | -5.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.39 |
| EV / Sales | 2.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -51.76% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | 6.45M |
| Profits Per Employee | -997,223 |
| Employee Count | 175 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -44.96M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.18% in the last 52 weeks. The beta is 0.54, so BOM:524636's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -35.18% |
| 50-Day Moving Average | 56.94 |
| 200-Day Moving Average | 78.61 |
| Relative Strength Index (RSI) | 29.96 |
| Average Volume (20 Days) | 22,559 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524636 had revenue of INR 1.13 billion and -174.51 million in losses. Loss per share was -4.74.
| Revenue | 1.13B |
| Gross Profit | -42.35M |
| Operating Income | -180.68M |
| Pretax Income | -219.48M |
| Net Income | -174.51M |
| EBITDA | -186.36M |
| EBIT | -180.68M |
| Loss Per Share | -4.74 |
Balance Sheet
The company has 12.40 million in cash and 728.29 million in debt, with a net cash position of -715.89 million or -19.36 per share.
| Cash & Cash Equivalents | 12.40M |
| Total Debt | 728.29M |
| Net Cash | -715.89M |
| Net Cash Per Share | -19.36 |
| Equity (Book Value) | -366.79M |
| Book Value Per Share | -9.89 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -3.75%, with operating and profit margins of -16.01% and -15.47%.
| Gross Margin | -3.75% |
| Operating Margin | -16.01% |
| Pretax Margin | -19.45% |
| Profit Margin | -15.47% |
| EBITDA Margin | -16.52% |
| EBIT Margin | -16.01% |
| FCF Margin | n/a |
Dividends & Yields
BOM:524636 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.33% |
| Shareholder Yield | -4.33% |
| Earnings Yield | -8.14% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |